These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8088927)

  • 1. Participation of serum proteins in the inflammation-primed activation of macrophages.
    Yamamoto N; Willett NP; Lindsay DD
    Inflammation; 1994 Jun; 18(3):311-22. PubMed ID: 8088927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.
    Yamamoto N; Homma S; Haddad JG; Kowalski MA
    Immunology; 1991 Nov; 74(3):420-4. PubMed ID: 1769691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.
    Yamamoto N; Naraparaju VR
    Cell Immunol; 1996 Jun; 170(2):161-7. PubMed ID: 8660814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.
    Yamamoto N; St Claire DA; Homma S; Ngwenya BZ
    Cancer Res; 1988 Nov; 48(21):6044-9. PubMed ID: 3167855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytes.
    Homma S; Millman I; Yamamoto N
    Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():137-42. PubMed ID: 1696561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation process of macrophages after in vitro treatment of mouse lymphocytes with dodecylglycerol.
    Homma S; Yamamoto N
    Clin Exp Immunol; 1990 Feb; 79(2):307-13. PubMed ID: 2178824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.
    Yamamoto N; Homma S; Millman I
    J Immunol; 1991 Jul; 147(1):273-80. PubMed ID: 2051023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of vitamin D3-binding protein in activation of mouse macrophages.
    Yamamoto N; Naraparaju VR
    J Immunol; 1996 Aug; 157(4):1744-9. PubMed ID: 8759764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats.
    Yamamoto N; Lindsay DD; Naraparaju VR; Ireland RA; Popoff SN
    J Immunol; 1994 May; 152(10):5100-7. PubMed ID: 8176226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D-binding protein (group-specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine.
    Homma S; Yamamoto M; Yamamoto N
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():249-57. PubMed ID: 8225394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.
    Yamamoto N; Homma S
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8539-43. PubMed ID: 1924312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of peritoneal macrophages by lysophosphatidylcholine.
    Ngwenya BZ; Yamamoto N
    Biochim Biophys Acta; 1985 Mar; 839(1):9-15. PubMed ID: 3978122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of peritoneal macrophages by orally administered ether analogues of lysophospholipids.
    Ngwenya BZ; Fiavey NP; Mogashoa MM
    Proc Soc Exp Biol Med; 1991 May; 197(1):91-7. PubMed ID: 1850526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.
    Yamamoto N; Kumashiro R
    J Immunol; 1993 Sep; 151(5):2794-802. PubMed ID: 8360493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neoplastic action of peritoneal macrophages following oral administration of ether analogues of lysophospholipids.
    Ngwenya BZ; Fiavey NP; Mogashoa MM
    Eur J Cancer; 1992; 28A(10):1637-42. PubMed ID: 1389479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of lysophosphatidylcholine-treated nonadherent cells to mechanism of macrophage activation.
    Ngwenya BZ; Yamamoto N
    Proc Soc Exp Biol Med; 1990 Feb; 193(2):118-24. PubMed ID: 2300592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antibody production by lysophosphatidylcholine and alkylglycerol.
    Ngwenya BZ; Foster DM
    Proc Soc Exp Biol Med; 1991 Jan; 196(1):69-75. PubMed ID: 1984244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of inflammation-primed activation of macrophages by two serum factors, vitamin D3-binding protein and albumin.
    Yamamoto N; Kumashiro R; Yamamoto M; Willett NP; Lindsay DD
    Infect Immun; 1993 Dec; 61(12):5388-91. PubMed ID: 8225612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages.
    Ngwenya BZ; Yamamoto N
    Cancer Immunol Immunother; 1986; 21(3):174-82. PubMed ID: 2938735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids.
    Yamamoto N; Ngwenya BZ
    Cancer Res; 1987 Apr; 47(8):2008-13. PubMed ID: 2950993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.